Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$46,371,342
+$3,607,789 QoQ
Shares Held
797,718
+8.4% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 329 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,792 across 523 Biotechnology names. PCVX ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in PCVX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,371,342 | 797,718 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $42,763,553 | 735,907 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $38,544,753 | 835,387 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $28,257,074 | 784,483 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $27,370,880 | 841,922 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $22,918,465 | 606,951 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $56,756,234 | 693,333 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $79,402,675 | 694,869 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $30,935,837 | 409,692 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $33,502,909 | 490,454 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $33,746,518 | 537,365 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $20,878,856 | 409,550 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $21,228,990 | 425,090 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,394,947 | 170,623 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,061,111 | 168,115 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,020,792 | 42,533 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,995,716 | 137,671 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,147,681 | 88,931 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,376,081 | 57,843 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $965,986 | 38,076 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $447,407 | 19,876 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $187,051 | 9,471 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $360,261 | 13,559 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $146,115 | 2,959 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,161 | 100 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||